DR ACKERMANS
ActiveSummary
DR ACKERMANS has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €11,022 and a net result of €57,909. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 15% of 20,659 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
10-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Highest result from 2022 to 2025net €57,909 ▲65.8%
Operating result €72,653, net result €57,909, both a record.
14-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
08-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial
Liquidity more than 5 timescurrent ratio 2.10
Current ratio from 0.40 to 2.10; short-term debt falls from €47,267 to €26,478.
28-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
14-11
Gazette deed
IncorporationAppointment: ACKERMANS Jennifer Christiane (director) · Founder · Founding capital7 facts ▸
Gazette deed
Incorporation
Appointment: ACKERMANS Jennifer Christiane (director) · Founder · Founding capital7 facts ▸
- Incorporation, 09-11-2022
- Founder, ACKERMANS Jennifer Christiane
- Founding capital, €3,500
- Bank account, “société en formation, BE17 7320 6689 7921” (deed in French)
- Registered office clause, “6950 Harsin-Nassogne, rue des Ecoles”, 31 (deed in French)
- Board rule, 1, “assemblee” (deed in French)
- Director appointment, ACKERMANS Jennifer Christiane (director (not named in the articles))
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 1 deed read